NBC
HAE icon

Neuberger Berman Canada’s Haemonetics HAE Stock Holding History

Neuberger Berman Canada’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,100
Closed -$453K – 219
2014
Q4 		$453K Buy
+12,100
New +$443K 0.07% 170

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Canada's HAE Position: Q1 2015 in Review

Neuberger Berman Canada sold out of Haemonetics (HAE) in Q1 2015, closing a stake of 12,100 shares — an estimated $453K sold.

Neuberger Berman Canada first reported a position in HAE in Q4 2014 and held it in 1 quarter. The position peaked at $453K in Q4 2014. 169 funds tracked by Wall St. Rank hold HAE as of Q1 2015.

  • Neuberger Berman Canada reported no remaining Haemonetics position as of Q1 2015 after selling out during the quarter.
  • Neuberger Berman Canada sold 12,100 Haemonetics shares in Q1 2015, an estimated $453K.
  • Neuberger Berman Canada first reported a position in Haemonetics in Q4 2014 and held it in 1 quarter.
  • Neuberger Berman Canada's Haemonetics position peaked at $453K in Q4 2014.
  • 169 funds tracked by Wall St. Rank held Haemonetics as of Q1 2015.

Based on Neuberger Berman Canada's 13F filing for Q1 2015, filed 30 Apr 2015.